Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea Ctenocephalides felis

IF 1.7 Q3 PARASITOLOGY
Norbert Mencke , Katrin Blazejak , Gabriele Petry , Hannah Hamburg , Hannah Ringeisen , Tanja N. Knoppe , Alta Viljoen , Ashley Smith , Jennifer Spruill
{"title":"Immediate and long-term efficacy of Felpreva®, a new spot-on formulation containing tigolaner, emodepside and praziquantel, applied as a single application to cats artificially infested with the cat flea Ctenocephalides felis","authors":"Norbert Mencke ,&nbsp;Katrin Blazejak ,&nbsp;Gabriele Petry ,&nbsp;Hannah Hamburg ,&nbsp;Hannah Ringeisen ,&nbsp;Tanja N. Knoppe ,&nbsp;Alta Viljoen ,&nbsp;Ashley Smith ,&nbsp;Jennifer Spruill","doi":"10.1016/j.crpvbd.2023.100122","DOIUrl":null,"url":null,"abstract":"<div><p>Five studies (two dose determination, two dose confirmation, and one speed of flea kill study) were conducted to assess the immediate (therapeutic) efficacy and long-term persistent (preventive) efficacy of a single spot-on application containing the novel acaricide and insecticide tigolaner in combination with emodepside and praziquantel (Felpreva®, Vetoquinol S.A. Lure, France) applied to cats artificially infested with <em>Ctenocephalides felis</em>. Eight cats per group were randomly allocated to 0, 1×, 1.3× and 2× of the minimum dose (14.5 ​mg/kg body weight) of tigolaner (dose determination studies) or randomly allocated to 0 and 1× of the dosage (dose confirmation studies). Onset of efficacy was assessed in a speed of flea kill study on an existing flea infestation 8, 12 and 24 ​h after treatment and reassessed after monthly flea reinfestation until 13 weeks post-treatment. Efficacy was calculated according to the Abbott formula using arithmetic means. Efficacy was claimed when (i) control groups were adequately infested (flea retention ≥ 50%) at each time-point in the studies; (ii) flea counts in treated groups were significantly lower (<em>P</em> ​≤ ​0.05) than flea counts in control groups; and (iii) calculated efficacy was ≥ 90% (speed of flea kill study) and ≥ 95% (dose determination and dose confirmation studies). Tigolaner at 14.5 ​mg/kg body weight was 100% effective against fleas on Day 1 (immediate, therapeutic efficacy) in both, dose determination and dose confirmation studies. The long-term persistent efficacy in week 13 ranged between 96.3% and 100%. Fleas were rapidly killed within 12 ​h after treatment (100% flea reduction, immediate efficacy). New flea infestations were successfully prevented for 8 weeks (98.9–100% flea reduction) within 8 ​h after reinfestation, and at week 13 (96.3% flea reduction) within 24 ​h after reinfestation.</p></div>","PeriodicalId":94311,"journal":{"name":"Current research in parasitology & vector-borne diseases","volume":"3 ","pages":"Article 100122"},"PeriodicalIF":1.7000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current research in parasitology & vector-borne diseases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667114X23000109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PARASITOLOGY","Score":null,"Total":0}
引用次数: 3

Abstract

Five studies (two dose determination, two dose confirmation, and one speed of flea kill study) were conducted to assess the immediate (therapeutic) efficacy and long-term persistent (preventive) efficacy of a single spot-on application containing the novel acaricide and insecticide tigolaner in combination with emodepside and praziquantel (Felpreva®, Vetoquinol S.A. Lure, France) applied to cats artificially infested with Ctenocephalides felis. Eight cats per group were randomly allocated to 0, 1×, 1.3× and 2× of the minimum dose (14.5 ​mg/kg body weight) of tigolaner (dose determination studies) or randomly allocated to 0 and 1× of the dosage (dose confirmation studies). Onset of efficacy was assessed in a speed of flea kill study on an existing flea infestation 8, 12 and 24 ​h after treatment and reassessed after monthly flea reinfestation until 13 weeks post-treatment. Efficacy was calculated according to the Abbott formula using arithmetic means. Efficacy was claimed when (i) control groups were adequately infested (flea retention ≥ 50%) at each time-point in the studies; (ii) flea counts in treated groups were significantly lower (P ​≤ ​0.05) than flea counts in control groups; and (iii) calculated efficacy was ≥ 90% (speed of flea kill study) and ≥ 95% (dose determination and dose confirmation studies). Tigolaner at 14.5 ​mg/kg body weight was 100% effective against fleas on Day 1 (immediate, therapeutic efficacy) in both, dose determination and dose confirmation studies. The long-term persistent efficacy in week 13 ranged between 96.3% and 100%. Fleas were rapidly killed within 12 ​h after treatment (100% flea reduction, immediate efficacy). New flea infestations were successfully prevented for 8 weeks (98.9–100% flea reduction) within 8 ​h after reinfestation, and at week 13 (96.3% flea reduction) within 24 ​h after reinfestation.

Abstract Image

Felpreva®的即时和长期疗效,这是一种新的定点制剂,含有tigolaner、emodepside和吡喹酮,可一次性应用于人工感染猫蚤Ctenocephalides felis的猫
进行了五项研究(两次剂量测定、两次剂量确认和一次跳蚤杀灭速度研究人工感染的猫栉头线虫。每组8只猫被随机分配到0、1×、1.3×和2×的最小剂量(14.5​mg/kg体重)的替戈拉纳(剂量确定研究)或随机分配到剂量的0和1倍(剂量确认研究)。在对现有跳蚤侵扰的跳蚤杀灭速度研究中评估了疗效的发作8、12和24​治疗后h,并在每月跳蚤再感染后重新评估,直到治疗后13周。根据Abbott公式使用算术方法计算疗效。当(i)对照组在研究的每个时间点都受到足够的感染(跳蚤滞留率≥50%)时,就声称有疗效;(ii)治疗组的跳蚤数量显著低于对照组(P​≤​0.05)显著高于对照组跳蚤数;和(iii)计算的疗效≥90%(跳蚤杀灭研究的速度)和≥95%(剂量测定和剂量确认研究)。14.5时的Tigolaner​在剂量测定和剂量确认研究中,mg/kg体重在第1天对跳蚤有100%的有效性(即时疗效)。第13周的长期持续疗效在96.3%-100%之间。跳蚤在12秒内被迅速杀死​治疗后h(跳蚤减少100%,立即有效)。新的跳蚤感染在8周内成功预防了8周(跳蚤减少98.9–100%)​再次受孕后h,第13周(跳蚤减少96.3%)24小时内​h。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信